196 related articles for article (PubMed ID: 24106926)
1. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.
Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; De Wit S; Phillips A; Lundgren JD; Sabin CA;
BMC Infect Dis; 2013 Oct; 13():471. PubMed ID: 24106926
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.
Bruyand M; Ryom L; Shepherd L; Fatkenheuer G; Grulich A; Reiss P; de Wit S; D Arminio Monforte A; Furrer H; Pradier C; Lundgren J; Sabin C;
J Acquir Immune Defic Syndr; 2015 Apr; 68(5):568-77. PubMed ID: 25763785
[TBL] [Abstract][Full Text] [Related]
3. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals.
Long JL; Engels EA; Moore RD; Gebo KA
AIDS; 2008 Feb; 22(4):489-96. PubMed ID: 18301061
[TBL] [Abstract][Full Text] [Related]
4. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
[TBL] [Abstract][Full Text] [Related]
5. Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis.
Krishnan S; Schouten JT; Jacobson DL; Benson CA; Collier AC; Koletar SL; Santana J; Sattler FR; Mitsuyasu R;
Oncology; 2011; 80(1-2):42-9. PubMed ID: 21606663
[TBL] [Abstract][Full Text] [Related]
6. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
[TBL] [Abstract][Full Text] [Related]
7. Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study.
Gotti D; Raffetti E; Albini L; Sighinolfi L; Maggiolo F; Di Filippo E; Ladisa N; Angarano G; Lapadula G; Pan A; Esposti AD; Fabbiani M; Focà E; Scalzini A; Donato F; Quiros-Roldan E;
PLoS One; 2014; 9(4):e94768. PubMed ID: 24760049
[TBL] [Abstract][Full Text] [Related]
8. A case-control study of non-AIDS-defining cancers in a prospective cohort of HIV-infected patients.
Rodríguez Arrondo F; von Wichmann MÁ; Camino X; Goenaga MÁ; Ibarguren M; Azcune H; Bustinduy MJ; Ferrero O; Muñoz J; Ibarra S; Aguirrebengoa K; Goicoetxea J; Bereciartua E; Montejo M; García MA; Martínez E; Portu J; Metola L; Silvariño R; Sarasqueta C; Arrizabalaga J; Iribarren JA;
Med Clin (Barc); 2018 Apr; 150(8):291-296. PubMed ID: 28528797
[TBL] [Abstract][Full Text] [Related]
9. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
10. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.
Achenbach CJ; Cole SR; Kitahata MM; Casper C; Willig JH; Mugavero MJ; Saag MS
AIDS; 2011 Mar; 25(5):691-700. PubMed ID: 21160411
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
Dauby N; De Wit S; Delforge M; Necsoi VC; Clumeck N
J Int AIDS Soc; 2011 Mar; 14():16. PubMed ID: 21443771
[TBL] [Abstract][Full Text] [Related]
12. HIV infection and the risk of cancers with and without a known infectious cause.
Silverberg MJ; Chao C; Leyden WA; Xu L; Tang B; Horberg MA; Klein D; Quesenberry CP; Towner WJ; Abrams DI
AIDS; 2009 Nov; 23(17):2337-45. PubMed ID: 19741479
[TBL] [Abstract][Full Text] [Related]
13. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.
Gesesew HA; Ward P; Woldemichael K; Mwanri L
PLoS One; 2018; 13(6):e0198815. PubMed ID: 29912974
[TBL] [Abstract][Full Text] [Related]
14. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
Int J Cancer; 2015 Nov; 137(10):2443-53. PubMed ID: 25976897
[TBL] [Abstract][Full Text] [Related]
15. CD4/CD8 Ratio and CD4 Nadir Predict Mortality Following Noncommunicable Disease Diagnosis in Adults Living with HIV.
Castilho JL; Turner M; Shepherd BE; Koethe JR; Furukawa SS; Bofill CE; Raffanti S; Sterling TR
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):960-967. PubMed ID: 31407605
[TBL] [Abstract][Full Text] [Related]
16. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
Monforte Ad; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law M; De Wit S; Friis-Møller N; Phillips AN; Sabin CA; Lundgren JD;
AIDS; 2008 Oct; 22(16):2143-53. PubMed ID: 18832878
[TBL] [Abstract][Full Text] [Related]
17. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
[TBL] [Abstract][Full Text] [Related]
18. Cancer in HIV-infected persons from the Caribbean, Central and South America.
Fink VI; Shepherd BE; Cesar C; Krolewiecki A; Wehbe F; Cortés CP; Crabtree-Ramírez B; Padgett D; Shafaee M; Schechter M; Gotuzzo E; Bacon M; McGowan C; Cahn P; Masys D;
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):467-73. PubMed ID: 21239992
[TBL] [Abstract][Full Text] [Related]
19. Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study.
Raffetti E; Albini L; Gotti D; Segala D; Maggiolo F; di Filippo E; Saracino A; Ladisa N; Lapadula G; Fornabaio C; Castelnuovo F; Casari S; Fabbiani M; Pierotti P; Donato F; Quiros-Roldan E;
BMC Public Health; 2015 Mar; 15():235. PubMed ID: 25884678
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
Silverman RA; John-Stewart GC; Beck IA; Milne R; Kiptinness C; McGrath CJ; Richardson BA; Chohan B; Sakr SR; Frenkel LM; Chung MH
PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]